• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDINOL LTD. ELUNIR¿ RIDAFOROLIMUS ELUTING CORONARY STENT SYSTEM; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDINOL LTD. ELUNIR¿ RIDAFOROLIMUS ELUTING CORONARY STENT SYSTEM; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number 3.0X33
Device Problems Positioning Failure (1158); Failure to Advance (2524); Deformation Due to Compressive Stress (2889); Material Deformation (2976)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 04/03/2018
Event Type  malfunction  
Manufacturer Narrative
Device not returned to manufacturer.
 
Event Description
During the catheterization procedure on the patient with a difficult case of chronic total occlusion (cto) balloons were employed to widen (pre-dilate) the right coronary artery (rca).Blockage was diagnosed in the distal region of the artery.The first stent was successfully implanted and opened correctly, in the distal region (lnrin00019 2.75*20).While attempting to insert a second stent next to the existing one to enhance treating a long lesion the physician experienced difficulty in the arterial passage (which was calcified and full of plaque) while using a lnrin00027 3*33 stent so he therefore pulled back to remove the stent for the purpose of re-inserting it for an additional attempt.While removing the stent from the artery and the patient's body, the operator noticed that the struts had opened and unraveled in the proximal area and the cylinder was opened and damaged.It was decided to implant a new stent in its place, also of the elunir type, (the third one being used, the second in the artery) lnrin00058 3.5*33.The stent was implanted and opened correctly.There was no injury nor damage to the patient; the artery remained open.Additional information received on april 29, 2018: the elunir stent delivery system was stored and handled according to the ifu.There was no damage noted to the product packaging upon inspection prior to use.No excessive force was applied to the device while removing the product from the packaging or while removing it from the patient's vessel.
 
Manufacturer Narrative
Attached: device analysis report, ifu review, final report.Investigation conclusion: the investigation findings do not lead to a clear conclusion about the cause of the reported adverse event.Attachment: [(b)(4)_device analysis report.Pdf, (b)(4)_ifu review.Pdf, (b)(4)-final report.Pdf].
 
Event Description
Complaint outside us.Additional information received: device analysis report (june 10, 2018) - see attached.Ifu review (june 11, 2018) - see attached.Final report (june 13, 2018) - see attached.
 
Manufacturer Narrative
Corrected data: in the previous mdr, submitted june 20, 2018, the ifu review was attached, with no ifu deviation reported.On august 22, 2018 it was realized that us ifu was reviewed (ifu #(b)(4)) instead of the correct international ifu (ifu #(b)(4)), since the event took place outside us.The correct ifu was reviewed on august 22, 2018.No deviation was reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELUNIR¿ RIDAFOROLIMUS ELUTING CORONARY STENT SYSTEM
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
MEDINOL LTD.
beck tech bldg
8 hartom st.
jerusalem, israel 97775 08
IS  9777508
MDR Report Key7482398
MDR Text Key107211626
Report Number3003084171-2018-00018
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier07290107013970
UDI-Public07290107013970
Combination Product (y/n)N
PMA/PMN Number
P170008
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor
Type of Report Initial,Followup,Followup
Report Date 04/09/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/03/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Physician
Device Expiration Date08/31/2019
Device Model Number3.0X33
Device Catalogue NumberLUN300R33IN
Device Lot NumberLNRIN00027
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/28/2018
Was the Report Sent to FDA? No
Date Manufacturer Received08/22/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-